Yuma Ebihara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuma Ebihara has a total of 208 co-authors. Here are the top co-authors by number of shared publications:
- Satoshi Hirano
Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan
45 shared publications Toshiaki Shichinohe
45 shared publicationsSatoshi Hirano
Department of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo, Japan
39 shared publicationsSoichi Murakami
Department of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan
38 shared publicationsYo Kurashima
Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan
38 shared publications- Toshiaki Shichinohe
Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan
35 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 61
Fiber-optic near-infrared fluorescence spectroscopy using indocyanine green for semi-quantitative time–intensity curve assessment of the gastric conduit before and after retrosternal reconstruction: an initial clinical study
- 25 August 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 61
Open AccessFiber-optic near-infrared fluorescence spectroscopy using indocyanine green for semi-quantitative time–intensity curve assessment of the gastric conduit before and after retrosternal reconstruction: an initial clinical study
- 27 March 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (4) , 2223-2237
Comparison of D2 and Non-D2 Lymphadenectomy in Older Patients (≥75 years) Undergoing Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-matched Analysis
This multicenter retrospective cohort study with propensity score matching (PSM) evaluated the surgical outcomes and prognosis of minimally invasive distal gastrectomy (MIDG) with D2 lymphadenectomy (LND) in older patients (≥75 years) with gastric cancer (GC). We retrospectively enrolled 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. Older patients with GC (cN+ or ≥cT2) were categorized into two groups: those who received D2 LND (D2 group) and those who did not (Non-D2 group). PSM was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method (Billroth I, Billroth II, or Roux-en-Y), adjuvant chemotherapy, and clinical T/N stage according to the Japanese Classification of Gastric Carcinoma. Surgical outcomes and prognoses were compared between groups. A total of 186 eligible patients were identified (D2: 74; Non-D2: 112), and 82 patients (41 per group) were included after matching. Operation time was significantly shorter in the Non-D2 group [D2: 349 min (176-507) vs. Non-D2: 285 min (138-458); p=0.025). The incidence of postoperative complications (Clavien-Dindo grade ≥II) was comparable between groups. The median follow-up was 23.3 months (range=1-79.4) in the D2 group and 26.2 months (range=1-79.5 months) in the Non-D2 group. No significant differences were observed in 5-year overall survival (D2: 47.7% vs. Non-D2: 34.6%; p=0.143) or 5-year relapse-free survival (RFS) (D2: 34.3% vs. Non-D2: 27.2%; p=0.578). Multivariable analysis identified pathological lymph node metastasis as an independent prognostic factor for RFS (hazard ratio= 3.553; 95% confidence interval=1.263-9.996; p=0.016). Among older patients (≥75 years) undergoing MIDG for GC, D2 LND was associated with longer operation time without significant differences in survival outcomes.
- 27 March 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (4) , 2223-2237
Comparison of D2 and Non-D2 Lymphadenectomy in Older Patients (≥75 years) Undergoing Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-matched Analysis
This multicenter retrospective cohort study with propensity score matching (PSM) evaluated the surgical outcomes and prognosis of minimally invasive distal gastrectomy (MIDG) with D2 lymphadenectomy (LND) in older patients (≥75 years) with gastric cancer (GC). We retrospectively enrolled 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. Older patients with GC (cN+ or ≥cT2) were categorized into two groups: those who received D2 LND (D2 group) and those who did not (Non-D2 group). PSM was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method (Billroth I, Billroth II, or Roux-en-Y), adjuvant chemotherapy, and clinical T/N stage according to the Japanese Classification of Gastric Carcinoma. Surgical outcomes and prognoses were compared between groups. A total of 186 eligible patients were identified (D2: 74; Non-D2: 112), and 82 patients (41 per group) were included after matching. Operation time was significantly shorter in the Non-D2 group [D2: 349 min (176-507) vs. Non-D2: 285 min (138-458); p=0.025). The incidence of postoperative complications (Clavien-Dindo grade ≥II) was comparable between groups. The median follow-up was 23.3 months (range=1-79.4) in the D2 group and 26.2 months (range=1-79.5 months) in the Non-D2 group. No significant differences were observed in 5-year overall survival (D2: 47.7% vs. Non-D2: 34.6%; p=0.143) or 5-year relapse-free survival (RFS) (D2: 34.3% vs. Non-D2: 27.2%; p=0.578). Multivariable analysis identified pathological lymph node metastasis as an independent prognostic factor for RFS (hazard ratio= 3.553; 95% confidence interval=1.263-9.996; p=0.016). Among older patients (≥75 years) undergoing MIDG for GC, D2 LND was associated with longer operation time without significant differences in survival outcomes.
- 10 March 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 336
Safety, technical transferability, and oncological outcomes of multi-institutional robotic distal gastrectomy for gastric cancer: impact of surgeons qualified under the endoscopic surgical skill qualification system of the Japan Society for Endoscopic Surgery
- 10 March 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 336
Safety, technical transferability, and oncological outcomes of multi-institutional robotic distal gastrectomy for gastric cancer: impact of surgeons qualified under the endoscopic surgical skill qualification system of the Japan Society for Endoscopic Surgery
- Open Access
- 27 February 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (2) , 992-1006
Male Sex as a Risk Factor for Perioperative Morbidity and Recurrence Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis
This study aimed to investigate the effect of sex-related differences on surgical outcomes, postoperative complications, and prognosis in patients undergoing minimally invasive distal gastrectomy (MIDG) for gastric cancer (GC). We retrospectively analyzed 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. The patients were categorized according to sex (male or female). To minimize selection bias, propensity score matching (PSM) was performed using the following covariates: age, body mass index, the American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method, adjuvant chemotherapy, clinical stage, postoperative complications (Clavien-Dindo classification: CD), and prognoses, including overall survival (OS), relapse-free survival (RFS), and Cancer-Specific Survival (CSS). Even after the PSM, male patients demonstrated significantly worse outcomes in surgical and long-term settings. Compared with the females, males had a longer median operation time (293 min vs. 274 min, pvs. 0 ml, pvs. 9.5%, p=0.037) than that in the female group. Multivariate logistic regression analysis identified male sex as an independent risk factor for postoperative complications (odds ratio: 1.727; 95% confidence interval=1.032-2.939; p=0.037). In a multivariate Cox regression analysis, male sex was as an independent risk factor for poorer RFS. Male patients undergoing MIDG face significantly higher risks of postoperative complications and cancer recurrence than female patients, independent of baseline clinical and pathological factors.
- 27 February 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (2) , 992-1006
Open AccessMale Sex as a Risk Factor for Perioperative Morbidity and Recurrence Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis
This study aimed to investigate the effect of sex-related differences on surgical outcomes, postoperative complications, and prognosis in patients undergoing minimally invasive distal gastrectomy (MIDG) for gastric cancer (GC). We retrospectively analyzed 988 patients who underwent MIDG for GC at five institutions between January 2018 and December 2024. The patients were categorized according to sex (male or female). To minimize selection bias, propensity score matching (PSM) was performed using the following covariates: age, body mass index, the American Society of Anesthesiologists physical status classification, surgical approach (laparoscopic or robotic), reconstruction method, adjuvant chemotherapy, clinical stage, postoperative complications (Clavien-Dindo classification: CD), and prognoses, including overall survival (OS), relapse-free survival (RFS), and Cancer-Specific Survival (CSS). Even after the PSM, male patients demonstrated significantly worse outcomes in surgical and long-term settings. Compared with the females, males had a longer median operation time (293 min vs. 274 min, pvs. 0 ml, pvs. 9.5%, p=0.037) than that in the female group. Multivariate logistic regression analysis identified male sex as an independent risk factor for postoperative complications (odds ratio: 1.727; 95% confidence interval=1.032-2.939; p=0.037). In a multivariate Cox regression analysis, male sex was as an independent risk factor for poorer RFS. Male patients undergoing MIDG face significantly higher risks of postoperative complications and cancer recurrence than female patients, independent of baseline clinical and pathological factors.
- 1 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70385
Short‐ and Long‐Term Outcomes of Transanal Total Mesorectal Excision for Rectal Cancer: A Single‐Center Retrospective Study of 100 Patients
Purpose: Transanal total mesorectal excision (TaTME) has been introduced to facilitate distal rectal dissection; however, concerns regarding its oncological safety persist. This study evaluated the outcomes of TaTME in a real‐world setting. Methods: Between 2019 and 2025, 123 patients underwent TaTME at our institution. After excluding patients with pathologically confirmed Stage IV disease, combined resection of adjacent organs, and local recurrence, 100 patients were retrospectively analyzed. Results: Median age was 67 years, and 64% were male. Median tumor distance from the anal verge was 6 cm. Procedures included low or ultra‐low anterior resection ( n = 67), intersphincteric resection ( n = 21), abdominoperineal resection ( n = 11), and Hartmann's procedure ( n = 1). A simultaneous two‐team approach, consisting of a surgeon and a camera assistant for each phase, was used in 98 patients. The median operative time and blood loss were 211.5 min and 5 mL, respectively. Median postoperative hospital stay was 15 days. Clavien–Dindo grade≥IIIa complications occurred in 12 patients, and no 90‐day mortality was observed. A positive circumferential resection margin was observed in one patient (1%). Median follow‐up was 1126 days. Recurrence occurred in 17 patients (17%), including pelvic local recurrence in four patients (4%). The estimated 3‐year overall survival (OS) rates for pathological Stages 0, I, II, and III were 100%, 100%, 90.0%, and 92.6%, respectively. The estimated 3‐year recurrence‐free survival (RFS) rates were 100%, 91.6%, 77.4%, and 66.6%, respectively. Conclusion: TaTME was associated with acceptable perioperative and oncological outcomes in a community hospital setting.
- 1 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70385
Short‐ and Long‐Term Outcomes of Transanal Total Mesorectal Excision for Rectal Cancer: A Single‐Center Retrospective Study of 100 Patients
Purpose: Transanal total mesorectal excision (TaTME) has been introduced to facilitate distal rectal dissection; however, concerns regarding its oncological safety persist. This study evaluated the outcomes of TaTME in a real‐world setting. Methods: Between 2019 and 2025, 123 patients underwent TaTME at our institution. After excluding patients with pathologically confirmed Stage IV disease, combined resection of adjacent organs, and local recurrence, 100 patients were retrospectively analyzed. Results: Median age was 67 years, and 64% were male. Median tumor distance from the anal verge was 6 cm. Procedures included low or ultra‐low anterior resection ( n = 67), intersphincteric resection ( n = 21), abdominoperineal resection ( n = 11), and Hartmann's procedure ( n = 1). A simultaneous two‐team approach, consisting of a surgeon and a camera assistant for each phase, was used in 98 patients. The median operative time and blood loss were 211.5 min and 5 mL, respectively. Median postoperative hospital stay was 15 days. Clavien–Dindo grade≥IIIa complications occurred in 12 patients, and no 90‐day mortality was observed. A positive circumferential resection margin was observed in one patient (1%). Median follow‐up was 1126 days. Recurrence occurred in 17 patients (17%), including pelvic local recurrence in four patients (4%). The estimated 3‐year overall survival (OS) rates for pathological Stages 0, I, II, and III were 100%, 100%, 90.0%, and 92.6%, respectively. The estimated 3‐year recurrence‐free survival (RFS) rates were 100%, 91.6%, 77.4%, and 66.6%, respectively. Conclusion: TaTME was associated with acceptable perioperative and oncological outcomes in a community hospital setting.
- 1 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70274
Surgical and Oncologic Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: Real‐World Data From a Multi‐Institutional Propensity Score‐Matched Study
Introduction: Robotic gastrectomy (RG) has been increasingly adopted for gastric cancer (GC). Although high‐volume centers report superior outcomes compared with laparoscopic gastrectomy (LG), real‐world evidence remains limited. This study compared short‐ and long‐term outcomes of robotic distal gastrectomy (RDG) and laparoscopic distal gastrectomy (LDG) using propensity score matching. Methods: Patients who underwent curative RDG or LDG between April 2018 and December 2024 were retrospectively reviewed. Propensity score matching was performed based on demographics, clinical factors, surgical procedures, pathological stage (Japanese Classification of Gastric Carcinoma), and perioperative chemotherapy. Surgical, postoperative, and oncological outcomes were compared. Results: Among 821 patients, 228 matched pairs were analyzed. Operative time was longer in the RDG group than in the LDG group (median 333 vs. 272.5 min, p < 0.0001). RDG was associated with lower rates of postoperative intra‐abdominal infectious complications, both overall and Clavien–Dindo grade ≥ II. Postoperative hospital stay was shorter in the RDG group (median 9 vs. 10 days, p = 0.0126). In patients with pathological stage III disease, operative time did not differ significantly between groups. The maximum postoperative serum C‐reactive protein level was lower in the RDG group, indicating a reduced inflammatory response. Overall and recurrence‐free survival did not differ significantly between groups. Conclusion: RDG was associated with fewer intra‐abdominal infections, shorter hospital stay, and reduced inflammatory response compared with LDG. For advanced GC (pStage III), RDG did not increase operative time and may provide clinical advantages. RG may be particularly beneficial for patients with advanced disease.
- 1 January 2026
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 19 (1) , e70274
Surgical and Oncologic Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: Real‐World Data From a Multi‐Institutional Propensity Score‐Matched Study
Introduction: Robotic gastrectomy (RG) has been increasingly adopted for gastric cancer (GC). Although high‐volume centers report superior outcomes compared with laparoscopic gastrectomy (LG), real‐world evidence remains limited. This study compared short‐ and long‐term outcomes of robotic distal gastrectomy (RDG) and laparoscopic distal gastrectomy (LDG) using propensity score matching. Methods: Patients who underwent curative RDG or LDG between April 2018 and December 2024 were retrospectively reviewed. Propensity score matching was performed based on demographics, clinical factors, surgical procedures, pathological stage (Japanese Classification of Gastric Carcinoma), and perioperative chemotherapy. Surgical, postoperative, and oncological outcomes were compared. Results: Among 821 patients, 228 matched pairs were analyzed. Operative time was longer in the RDG group than in the LDG group (median 333 vs. 272.5 min, p < 0.0001). RDG was associated with lower rates of postoperative intra‐abdominal infectious complications, both overall and Clavien–Dindo grade ≥ II. Postoperative hospital stay was shorter in the RDG group (median 9 vs. 10 days, p = 0.0126). In patients with pathological stage III disease, operative time did not differ significantly between groups. The maximum postoperative serum C‐reactive protein level was lower in the RDG group, indicating a reduced inflammatory response. Overall and recurrence‐free survival did not differ significantly between groups. Conclusion: RDG was associated with fewer intra‐abdominal infections, shorter hospital stay, and reduced inflammatory response compared with LDG. For advanced GC (pStage III), RDG did not increase operative time and may provide clinical advantages. RG may be particularly beneficial for patients with advanced disease.
- 29 November 2025
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 45 (12) , 5619-5631
Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer
Background/Aim: The relationship between postoperative complications and prognosis after laparoscopic distal gastrectomy (LDG) for gastric cancer (GC) remains controversial. This study evaluated this association using propensity score-matched analysis. Patients and Methods: We analyzed data of 590 patients who underwent curative LDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into non-complication and complication groups (non-CG and CG, respectively), with complications defined as Clavien–Dindo grade ≥II (CD ≥II). Minor complications were defined as CD grades I or II, and major complications were defined as CD grades ≥III. Propensity score matching (PSM) was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, reconstruction method, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Survival curves were compared using the log-rank test, and multivariate analysis was performed using the Cox proportional hazard models. Results: Overall incidence of postoperative complications (CD ≥II) was 14.9% (88/590 patients). After the PSM (85 pairs), the CG group had a significantly longer postoperative hospital stay than the non-CG group [median (range), 18 (7-110) days vs. 9 (5-18) days; pp=0.009), and 5-year relapse-free survival rate was 87.7% in the non-CG group and 70.9% in the CG group (p=0.027). Multivariable analysis identified age ≥80 years, postoperative complications (CD ≥II), and lymph node metastasis (pN) as independent prognostic factors for OS. Conclusion: Reducing the incidence of postoperative complications (CD ≥II) may improve prognosis in patients with GC undergoing LDG, contributing to better treatment strategies for GC.
- 29 November 2025
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 45 (12) , 5619-5631
Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer
Background/Aim: The relationship between postoperative complications and prognosis after laparoscopic distal gastrectomy (LDG) for gastric cancer (GC) remains controversial. This study evaluated this association using propensity score-matched analysis. Patients and Methods: We analyzed data of 590 patients who underwent curative LDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into non-complication and complication groups (non-CG and CG, respectively), with complications defined as Clavien–Dindo grade ≥II (CD ≥II). Minor complications were defined as CD grades I or II, and major complications were defined as CD grades ≥III. Propensity score matching (PSM) was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, reconstruction method, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Survival curves were compared using the log-rank test, and multivariate analysis was performed using the Cox proportional hazard models. Results: Overall incidence of postoperative complications (CD ≥II) was 14.9% (88/590 patients). After the PSM (85 pairs), the CG group had a significantly longer postoperative hospital stay than the non-CG group [median (range), 18 (7-110) days vs. 9 (5-18) days; pp=0.009), and 5-year relapse-free survival rate was 87.7% in the non-CG group and 70.9% in the CG group (p=0.027). Multivariable analysis identified age ≥80 years, postoperative complications (CD ≥II), and lymph node metastasis (pN) as independent prognostic factors for OS. Conclusion: Reducing the incidence of postoperative complications (CD ≥II) may improve prognosis in patients with GC undergoing LDG, contributing to better treatment strategies for GC.
- 8 October 2025
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 35 (6)
Comparison of Clinical Outcomes Between Billroth-I and Roux-en-Y Reconstruction Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-Matched Analysis
Purpose: Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching. Methods: This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared. Results: Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P P =0.042], and greater median blood loss ( P =0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II ( P P =0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P =0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups ( P =0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS. Conclusions: Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.
- 8 October 2025
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 35 (6)
Comparison of Clinical Outcomes Between Billroth-I and Roux-en-Y Reconstruction Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-Matched Analysis
Purpose: Gastric cancer (GC) is the third leading cause of cancer deaths, with surgery as the primary treatment; however, the outcomes of different types of surgeries still need to be understood further. This study evaluated the surgical outcomes and prognosis after minimally invasive distal gastrectomy (MIDG) for GC in a multicenter retrospective cohort using propensity score matching. Methods: This study retrospectively enrolled 688 patients who underwent curative MIDG for GC at five institutions between January 2018 and December 2024. Patients were categorized into Billroth-I reconstruction (B-I) and Roux-en-Y (R-Y) reconstruction groups. Propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, extent of lymph node dissection, Japanese Classification of Gastric Carcinoma stage, neoadjuvant chemotherapy, and adjuvant chemotherapy. Surgical outcomes and prognoses were compared. Results: Three hundred propensity score-matched pairs were identified. The R-Y group had longer median operation time [309 (131 to 531) min vs. 265 (126 to 532) min; P P =0.042], and greater median blood loss ( P =0.047) than the B-I group. Complications of Clavien-Dindo (CD) grade II ( P P =0.027) were more frequent in the R-Y group than in the B-I group. Five-year overall survival (OS) was significantly higher in the B-I group than in the R-Y group (91.1% vs. 83.4%; P =0.019), whereas 5-year relapse-free survival (RFS) showed no significant difference between these 2 groups ( P =0.056). Independent prognostic factors included reconstruction method, postoperative complications (≥CD III), and lymph node metastasis (pN) for OS and age (≥80), pT, and pN for RFS. Conclusions: Patients who underwent R-Y reconstruction had more frequent postoperative complications than those who underwent B-I reconstruction after MIDG. Although not significantly associated with RFS, these complications may affect OS. The findings of this study could help develop strategies for improving GC treatment.
- 6 January 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (9) , 1335-1339
Tele-robot-assisted minimally invasive esophagectomy using a double-surgeon cockpit on a cadaver
We conducted this study to evaluate the efficacy of robot-assisted minimally invasive esophagectomy (RAMIE) on cadavers in the prone position, utilizing telesurgical support through the double-surgeon cockpit (double SC) of the novel Japanese-made surgical robot system, hinotori™ (Medicaroid, Kobe, Japan). The Cadaveric Anatomy and Surgical Training Laboratory (CAST Lab) at Hokkaido University and Kushiro City General Hospital (KCGH) are interconnected by a dedicated 1 Gbps internet line, spanning 300 km. An operation unit and double SC were installed at CAST Lab, whereas the double SC proctor was installed at KCGH. RAMIE was performed with telesurgical support on two adult cadavers. The onsite and proctor operation times were recorded as 88/79 min and 64/75 min, respectively. Throughout the surgical procedures, communication remained stable, with an average communication delay of 13.1 ms (range: 11.0–15.0 ms). This study demonstrated the feasibility of performing RAMIE with the patient in the prone position, supported by telesurgical support using a double SC on the hinotori™ platform.
- 6 January 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (9) , 1335-1339
Tele-robot-assisted minimally invasive esophagectomy using a double-surgeon cockpit on a cadaver
We conducted this study to evaluate the efficacy of robot-assisted minimally invasive esophagectomy (RAMIE) on cadavers in the prone position, utilizing telesurgical support through the double-surgeon cockpit (double SC) of the novel Japanese-made surgical robot system, hinotori™ (Medicaroid, Kobe, Japan). The Cadaveric Anatomy and Surgical Training Laboratory (CAST Lab) at Hokkaido University and Kushiro City General Hospital (KCGH) are interconnected by a dedicated 1 Gbps internet line, spanning 300 km. An operation unit and double SC were installed at CAST Lab, whereas the double SC proctor was installed at KCGH. RAMIE was performed with telesurgical support on two adult cadavers. The onsite and proctor operation times were recorded as 88/79 min and 64/75 min, respectively. Throughout the surgical procedures, communication remained stable, with an average communication delay of 13.1 ms (range: 11.0–15.0 ms). This study demonstrated the feasibility of performing RAMIE with the patient in the prone position, supported by telesurgical support using a double SC on the hinotori™ platform.